Annual CFO
-$33.10 M
+$50.66 M+60.48%
31 December 2022
Summary:
Catalyst Biosciences annual cash flow from operations is currently -$33.10 million, with the most recent change of +$50.66 million (+60.48%) on 31 December 2022. During the last 3 years, it has risen by +$50.66 million (+60.48%).CBIO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$3.22 M
-$746.00 K-30.19%
30 September 2023
Summary:
Catalyst Biosciences quarterly cash flow from operations is currently -$3.22 million, with the most recent change of -$746.00 thousand (-30.19%) on 30 September 2023.CBIO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$13.38 M
+$4.06 M+23.28%
30 September 2023
Summary:
Catalyst Biosciences TTM cash flow from operations is currently -$13.38 million, with the most recent change of +$4.06 million (+23.28%) on 30 September 2023.CBIO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | +60.5% | +81.8% | +84.0% |
5 y5 years | +24.1% | +60.2% | +69.3% |
CBIO Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time | -123.9% | -101.8% | -108.3% |
Catalyst Biosciences Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2023 | - | -$3.22 M(+30.2%) | -$13.38 M(-23.3%) |
June 2023 | - | -$2.47 M(-60.2%) | -$17.44 M(-36.0%) |
Mar 2023 | - | -$6.22 M(+321.4%) | -$27.26 M(-17.6%) |
Dec 2022 | -$33.10 M(-60.5%) | -$1.48 M(-79.7%) | -$33.10 M(-32.9%) |
Sept 2022 | - | -$7.28 M(-40.8%) | -$49.30 M(-22.5%) |
June 2022 | - | -$12.29 M(+2.0%) | -$63.62 M(-11.0%) |
Mar 2022 | - | -$12.05 M(-31.8%) | -$71.45 M(-14.7%) |
Dec 2021 | -$83.75 M(+52.1%) | -$17.68 M(-18.2%) | -$83.75 M(-5.0%) |
Sept 2021 | - | -$21.60 M(+7.3%) | -$88.19 M(+10.8%) |
June 2021 | - | -$20.12 M(-17.4%) | -$79.60 M(+6.7%) |
Mar 2021 | - | -$24.36 M(+10.1%) | -$74.61 M(+35.5%) |
Dec 2020 | -$55.05 M(+26.2%) | -$22.11 M(+70.0%) | -$55.05 M(+34.2%) |
Sept 2020 | - | -$13.01 M(-14.1%) | -$41.02 M(+10.5%) |
June 2020 | - | -$15.14 M(+216.0%) | -$37.12 M(+11.0%) |
Mar 2020 | - | -$4.79 M(-40.8%) | -$33.45 M(-23.3%) |
Dec 2019 | -$43.61 M(+52.7%) | -$8.09 M(-11.1%) | -$43.61 M(-2.1%) |
Sept 2019 | - | -$9.10 M(-20.6%) | -$44.53 M(+4.9%) |
June 2019 | - | -$11.47 M(-23.3%) | -$42.46 M(+10.6%) |
Mar 2019 | - | -$14.96 M(+66.0%) | -$38.40 M(+34.5%) |
Dec 2018 | -$28.55 M(+43.2%) | -$9.01 M(+28.3%) | -$28.55 M(+10.4%) |
Sept 2018 | - | -$7.02 M(-5.3%) | -$25.86 M(+8.8%) |
June 2018 | - | -$7.41 M(+45.2%) | -$23.77 M(+14.5%) |
Mar 2018 | - | -$5.11 M(-19.2%) | -$20.75 M(+4.1%) |
Dec 2017 | -$19.94 M(+7.9%) | -$6.32 M(+28.2%) | -$19.94 M(+7.2%) |
Sept 2017 | - | -$4.93 M(+12.0%) | -$18.60 M(-1.0%) |
June 2017 | - | -$4.40 M(+2.6%) | -$18.78 M(+4.2%) |
Mar 2017 | - | -$4.29 M(-13.8%) | -$18.02 M(-2.4%) |
Dec 2016 | -$18.47 M(-3.4%) | -$4.98 M(-2.6%) | -$18.47 M(-0.9%) |
Sept 2016 | - | -$5.11 M(+40.3%) | -$18.64 M(+5.5%) |
June 2016 | - | -$3.64 M(-23.2%) | -$17.66 M(-9.0%) |
Mar 2016 | - | -$4.74 M(-7.7%) | -$19.41 M(+1.6%) |
Dec 2015 | -$19.12 M(-44.6%) | -$5.14 M(+24.4%) | -$19.12 M(+12.3%) |
Sept 2015 | - | -$4.13 M(-23.4%) | -$17.03 M(-17.2%) |
June 2015 | - | -$5.40 M(+21.4%) | -$20.57 M(-14.6%) |
Mar 2015 | - | -$4.45 M(+45.7%) | -$24.08 M(-30.2%) |
Dec 2014 | -$34.48 M | -$3.05 M(-60.2%) | -$34.48 M(-19.1%) |
Sept 2014 | - | -$7.67 M(-13.9%) | -$42.60 M(-4.6%) |
June 2014 | - | -$8.91 M(-40.0%) | -$44.64 M(-3.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2014 | - | -$14.85 M(+32.9%) | -$46.14 M(+13.6%) |
Dec 2013 | -$40.61 M(-36.8%) | -$11.17 M(+15.0%) | -$40.61 M(-1.1%) |
Sept 2013 | - | -$9.71 M(-6.8%) | -$41.05 M(-1.7%) |
June 2013 | - | -$10.41 M(+11.7%) | -$41.74 M(-14.2%) |
Mar 2013 | - | -$9.32 M(-19.7%) | -$48.66 M(-24.3%) |
Dec 2012 | -$64.24 M(-23.3%) | -$11.60 M(+11.5%) | -$64.24 M(-12.2%) |
Sept 2012 | - | -$10.40 M(-40.0%) | -$73.17 M(-9.5%) |
June 2012 | - | -$17.34 M(-30.4%) | -$80.84 M(-6.6%) |
Mar 2012 | - | -$24.90 M(+21.3%) | -$86.57 M(+3.4%) |
Dec 2011 | -$83.72 M(-160.5%) | -$20.53 M(+13.5%) | -$83.72 M(+6.1%) |
Sept 2011 | - | -$18.08 M(-21.6%) | -$78.90 M(+1.4%) |
June 2011 | - | -$23.06 M(+4.6%) | -$77.81 M(+33.9%) |
Mar 2011 | - | -$22.05 M(+40.3%) | -$58.10 M(-142.0%) |
Dec 2010 | $138.30 M(-669.8%) | -$15.71 M(-7.5%) | $138.30 M(-2.8%) |
Sept 2010 | - | -$16.99 M(+407.3%) | $142.28 M(-11.8%) |
June 2010 | - | -$3.35 M(-101.9%) | $161.24 M(+2.1%) |
Mar 2010 | - | $174.35 M(-1586.7%) | $157.87 M(-750.4%) |
Dec 2009 | -$24.27 M(-14.1%) | -$11.73 M(-696.8%) | -$24.27 M(+39.7%) |
Sept 2009 | - | $1.97 M(-129.2%) | -$17.37 M(-37.1%) |
June 2009 | - | -$6.72 M(-13.7%) | -$27.63 M(-5.8%) |
Mar 2009 | - | -$7.79 M(+61.3%) | -$29.33 M(+3.8%) |
Dec 2008 | -$28.26 M(-213.8%) | -$4.83 M(-41.8%) | -$28.26 M(+20.4%) |
Sept 2008 | - | -$8.29 M(-1.6%) | -$23.47 M(-1537.3%) |
June 2008 | - | -$8.42 M(+25.4%) | $1.63 M(-58.7%) |
Mar 2008 | - | -$6.72 M(>+9900.0%) | $3.96 M(-84.1%) |
Dec 2007 | $24.84 M(-351.1%) | -$39.50 K(-100.2%) | $24.84 M(+21.0%) |
Sept 2007 | - | $16.81 M(-375.6%) | $20.53 M(-3795.1%) |
June 2007 | - | -$6.10 M(-143.1%) | -$555.70 K(-138.0%) |
Mar 2007 | - | $14.16 M(-426.0%) | $1.46 M(-114.8%) |
Dec 2006 | -$9.89 M(-62.3%) | -$4.34 M(+1.6%) | -$9.89 M(-11.2%) |
Sept 2006 | - | -$4.28 M(+4.8%) | -$11.14 M(-18.8%) |
June 2006 | - | -$4.08 M(-245.3%) | -$13.71 M(-16.6%) |
Mar 2006 | - | $2.81 M(-150.3%) | -$16.44 M(-37.4%) |
Dec 2005 | -$26.25 M(+4.8%) | -$5.59 M(-18.4%) | -$26.25 M(+27.1%) |
Sept 2005 | - | -$6.85 M(+0.5%) | -$20.66 M(+49.6%) |
June 2005 | - | -$6.81 M(-2.6%) | -$13.81 M(+97.4%) |
Mar 2005 | - | -$7.00 M | -$7.00 M |
Dec 2004 | -$25.04 M | - | - |
FAQ
- What is Catalyst Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Catalyst Biosciences?
- What is Catalyst Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Catalyst Biosciences?
What is Catalyst Biosciences annual cash flow from operations?
The current annual CFO of CBIO is -$33.10 M
What is the all time high annual CFO for Catalyst Biosciences?
Catalyst Biosciences all-time high annual cash flow from operations is $138.30 M
What is Catalyst Biosciences quarterly cash flow from operations?
The current quarterly CFO of CBIO is -$3.22 M
What is the all time high quarterly CFO for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly cash flow from operations is $174.35 M
What is Catalyst Biosciences TTM cash flow from operations?
The current TTM CFO of CBIO is -$13.38 M
What is the all time high TTM CFO for Catalyst Biosciences?
Catalyst Biosciences all-time high TTM cash flow from operations is $161.24 M